“All in vivo toxicity studies were conducted in cynomolgus monkeys which can be considered as a relevant species for evaluation of safety of anifrolumab.”
Binding and neutralisation activity of anifrolumab in monkey cells
“Cynomolgus monkey was selected as the pharmacologically relevant toxicology model for nonclinical safety assessment based on binding and neutralisation activity of anifrolumab in monkey cells.”
No surrogate; the clinical antibody was tested in cynomolgus monkeys
“All in vivo toxicity studies were conducted in cynomolgus monkeys which can be considered as a relevant species for evaluation of safety of anifrolumab.”